Genetic Education in BRCA Families
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Georgetown University
- Study ID
- NCT03544983
- Status
- Enrolling By Invitation
Conditions
- BRCA1 Mutation
- BRCA2 Mutation
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Web + Streamlined Telephone Genetic Information — BEHAVIORALTailored and interactive web-based education designed to incorporate all aspects of standard genetic counseling followed by a streamlined genetic counseling session with a board-certified genetic counselor.
Study Details
The primary goal of this research is to test a web-based genetic education intervention that is designed to educate men and women from hereditary cancer families about the personal relevance of genetic testing in order to help them male decisions about whether to pursue genetic testing. We will test this intervention against standard care for men and women from hereditary cancer families. The web-based educational intervention includes all of the information typically covered during genetic counseling. As a result, after completing the education intervention, participants can proceed directly to a brief telephone call with a genetic counselor followed by testing if they choose. A baseline survey will be administered prior to randomization and then follow-up surveys will be administered at 1-month and 6-months post-randomization. Primary outcomes will be completion of genetic counseling, uptake of genetic testing, genetic test results and quality of life.
Key Dates
- Start date
- May 1, 2020
- Status verified
- Oct 2025
- Primary completion
- Dec 31, 2026
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 240 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Proactive Outreach + Web CounselingWeb + Streamlined Telephone Genetic Information
- No Intervention: Usual CareParticipants in the usual care arm will not be provided with access to the web-based intervention nor will they have access to streamlined genetic counseling. They can pursue clinical genetic counseling on their own.
Primary Outcome Measure
Uptake of genetic counseling and testing [ Time Frame: 6-months post randomization ]
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| George Washington University | Washington D.C. | District of Columbia | 20052 | - |
| Georgetown University Medical Center/Lombardi Comprehensive Cancer Center | Washington D.C. | District of Columbia | 20007 | - |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | - |
| Geisinger Medical Center | Danville | Pennsylvania | 17822 | - |
Find similar trials in Washington D.C., DC
Related Studies
- SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem CellsPHASE1 · Recruiting · General Oncology, Inc. · Boston, Massachusetts
- Prostate Cancer Genetic Risk Evaluation and Screening StudyRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene AlterationsPHASE2 · Recruiting · Rana McKay, MD · La Jolla, California
- A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesPHASE1/PHASE2 · Recruiting · 858 Therapeutics, Inc. · Phoenix, Arizona